Modeling Graves' Orbitopathy in Experimental Graves' Disease

Area of Science:

• Immunology
• Ophthalmology
• Endocrinology

Background:

• Graves' orbitopathy (GO), or thyroid eye disease, is an inflammatory orbital condition linked to autoimmune thyroid disease.
• Existing preclinical models for Graves' disease have limitations in addressing orbital complications.

Purpose of the Study:

• To establish a novel, stable preclinical mouse model for Graves' orbitopathy (GO).
• To investigate the pathophysiology and progression of GO using this new model.

Main Methods:

• Development of a mouse model using immunogenic presentation of human TSHR A-subunit plasmid via electroporation.
• Characterization of orbital pathologies, including inflammation and adipogenesis, in the developed model.
• Replication of the model in independent laboratories.

Main Results:

• The model successfully induced prolonged functional antibodies to TSHR, leading to chronic GO.
• Observed pathologies included orbital remodeling, inflammation (CD3+ T cells, macrophages), and adipogenesis.
• Eyelid inflammation with chemosis and vascular congestion were also noted.

Conclusions:

• This new preclinical model accurately mimics human Graves' orbitopathy.
• It provides a foundation for studying the roles of immune cells in GO initiation and progression.
• The model will aid in developing targeted therapies for orbital complications.